EFFICACY AND SAFETY OF BUDESONIDE AS FIRST LINE TREATMENT IN PATIENTS WITH AUTOIMMUNE HEPATITIS: SPANISH MULTICENTER STUDY

被引：0

作者：

Diaz-Gonzalez, Alvaro ^{[1
,2
]}

Hernandez-Guerra, Manuel ^{[3
]}

Gomez, Elena ^{[4
]}

Sapena, Victor ^{[5
]}

Perez-Medrano, Indhira ^{[6
]}

Del Barrio, Maria ^{[7
]}

Escude, Laia ^{[8
]}

Riveiro Barciela, Mar ^{[9
]}

Barreira-Diaz, Ana ^{[9
]}

Soria, Anna ^{[10
]}

Molina, Esther ^{[11
]}

Ferre-Aracil, Carlos ^{[12
]}

El Hajra, Ismael ^{[12
]}

Arencibia, Ana C. ^{[13
]}

Morillas Cunill, Rosa M. ^{[14
]}

Gomez-Camarero, Judith ^{[15
]}

Conde, Isabel ^{[16
]}

Mateos, Beatriz ^{[17
]}

Horta, Diana ^{[18
]}

Estevez, Pamela ^{[19
]}

Lopez, Carmen ^{[20
]}

Navascues, Carmen A. ^{[21
]}

Zamora, Javier ^{[22
]}

Garcia-Retortillo, Montserrat ^{[23
]}

Fernandez, Ainhoa ^{[24
]}

Crespo Garcia, Javier ^{[25
]}

Carlota Londono, Maria ^{[26
]}

机构：

[1] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[2] Hosp Univ Marques De Valdecilla, Santander, Spain

[3] Univ Hosp Canary Isl, Dept Gastroenterol, San Cristobal Laguna, Spain

[4] Hosp Univ 12 Octubre, Digest Dis Dept, Madrid, Spain

[5] Hosp Clin Barcelona, IDIBAPS, Med Stat Core Facil, Barcelona, Spain

[6] Complejo Hosp Univ Pontevedra, Digest Dis Dept, Pontevedra, Spain

[7] Marques De Valdecilla Univ Hosp, Gastroenterol & Hepatol, Santander, Spain

[8] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

[9] Hosp Univ Vall Dhebron, Dept Internal Med, Liver Unit, Barcelona, Spain

[10] Univ Autonoma Barcelona, Parc Tauli Hosp Univ, I3PT, Liver Unit, Sabadell, Spain

[11] Complejo Hosp Univ Santiago, Digest Dis Dept, Santiago De Compostela, Spain

[12] Hosp Univ Puerta De Hierro Majadahonda, Digest Dis Dept, Madrid, Spain

[13] Hosp Univ Nuestra Senora Candelaria, Liver Unit, Santa Cruz De Tenerife, Spain

[14] Hosp Badalona Germans Trias & Pujol, Hepatol Unit, Barcelona, Spain

[15] Hosp Univ Burgos, Burgos, Spain

[16] Hosp Univ & Politecn La Fe, Inst Invest Sanitaria La Fe, Digest Dis Dept, Valencia, Spain

[17] HU Ramon y Cajal, Gastroenterol, Madrid, Spain

[18] Hosp Univ Mutua Terrassa, Digest Dis Dept, Terrassa, Spain

[19] Hosp Univ Alvaro Cunqueiro, Digest Dis Dept, Vigo, Spain

[20] Hosp Univ Josep Trueta, Digest Dis Dept, Girona, Spain

[21] Hosp Univ Cent Asturias, Liver Unit, Div Gastroenterol & Hepatol, Oviedo, Spain

[22] Hosp Univ Reina Sofia, Digest Dis Dept, Cordoba, Spain

[23] Hosp Del Mar, Serv Digest, Secc Hepatol, Barcelona, Spain

[24] Hosp Gen Univ Gregorio Maranon, Digest Dis Dept, Madrid, Spain

[25] Hosp Univ Marques De Valdecilla, Digest Dis Dept, Inst Invest Sanitaria Valdecilla, Santander, Spain

[26] Hosp Clin Barcelona, Liver Unit, Barcelona, Spain

来源：

HEPATOLOGY | 2021年 / 74卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1268

引用

页码：761A / 762A

页数：2

共 50 条

[31] Epithelioid sarcoma: A retrospective study of efficacy and safety of first-line treatment
Zhang, C.
Li, W.
Guo, X.
You, Y.
Wang, Z.
Zhou, Y.
ANNALS OF ONCOLOGY, 2024, 35
[32] Budesonide versus prednisolone in the treatment of autoimmune hepatitis: a cross-sectional patients' survey
Oztumer, Ceyhun
Al-Rubaiy, Laith
JOURNAL OF HEPATOLOGY, 2021, 75 : S442 - S442
[33] Should MMF treatment be the first-line therapy in autoimmune hepatitis?
Alric, Laurent
JOURNAL OF HEPATOLOGY, 2024, 81 (01) : e40 - e40
[34] Antimitochondrial antibodies in patients with autoimmune hepatitis: a large multicenter study
Gatselis, Nikolaos
Zachou, Kalliopi
Montano-Loza, Aldo
Cancado, Eduardo Luiz Rachid
Arinaga-Hino, Teruko
Muratori, Paolo
Efe, Cumali
Floreani, Annarosa
Invernizzi, Pietro
Takahashi, Atsushi
Takaki, Akinobu
Beretta-Piccoli, Benedetta Terziroli
Van Hoek, Bart
Lytvyak, Ellina
Guedes, Laura Vilar
Purnak, Tugrul
Cazzagon, Nora
Lygoura, Vasiliki
Arvaniti, Pinelopi
Rigopoulou, Eirini
Muratori, Luigi
Dalekos, George
JOURNAL OF HEPATOLOGY, 2020, 73 : S471 - S471
[35] Treatment of autoimmune hepatitis: Budesonide does not solve our problems
Steinmann, Silja
Lohse, Ansgar W.
HEPATOLOGY, 2023, 77 (04) : 1071 - 1073
[36] Oral budesonide for the treatment of autoimmune hepatitis in case of intolerance to prednisolone
Audeguy, P
Signoret, C
PRESSE MEDICALE, 1999, 28 (04): : 176 - 176
[37] A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis
Zachou, K.
Gatselis, N. K.
Arvaniti, P.
Gabeta, S.
Rigopoulou, E. I.
Koukoulis, G. K.
Dalekos, G. N.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (10) : 1035 - 1047
[38] The safety and efficacy of losartan/hydrochlorothiazide in the treatment of patients with severe hypertension; A multicenter study
Aurup, P
Smith, RD
Snavely, D
Oparil, S
JOURNAL OF HYPERTENSION, 2000, 18 : S99 - S99
[39] Efficacy and safety of calcineurin inhibitors as salvage therapy in patients with autoimmune hepatitis
Strasser, S. I.
Stoklosa, T.
Lim, R.
Mitchell, J.
Nicoll, A. J.
Stuart, K.
Gow, P.
Macquillan, G.
Section, J. George Section
Mitchell, J.
Kemp, W.
McCaughan, G. W.
Roberts, S. K.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 71 - 72
[40] Efficacy and safety of calcineurin inhibitors as salvage therapy in patients with autoimmune hepatitis
Strasser, S.
Lim, R.
Mitchell, J.
Nicoll, A.
Stuart, K.
Gow, P.
Macquillan, G.
George, J.
Mitchell, J.
Kemp, W.
Mccaughan, G.
Roberts, S.
JOURNAL OF HEPATOLOGY, 2018, 68 : S233 - S234

← 1 2 3 4 5 →